Mouwasat Medical Services Co

SAU:4002HealthcareTADAWUL:THEItasi

——At close · Market cap — · Next earnings Thu 29 Oct

SAR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	2.0	2.1	2.3	2.7	2.9	3.2	3.4	+4.6%
Cost of revenue	1.1	1.1	1.2	1.4	1.6	1.9	2.0	+5.3%
Gross profit	1.0	1.0	1.1	1.3	1.3	1.3	1.4	+3.7%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Selling, general & administrative	0.1	0.1	0.1	0.1	0.1	0.1	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	0.4	0.4	0.4	0.5	0.6	0.4	0.5	+11.3%
Operating income	0.6	0.6	0.7	0.8	0.7	0.9	0.9	−0.2%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	+155.0%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−30.9%
Other income / expense	(0.0)	0.0	(0.0)	(0.0)	(0.0)	0.0	—	—
Pre-tax income	0.6	0.6	0.7	0.7	0.7	0.9	0.9	+1.5%
Income tax	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−48.8%
Net income	0.5	0.6	0.6	0.7	0.6	0.8	0.9	+3.5%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	2.64	2.89	3.00	3.29	3.24	4.11	4.26	+3.6%
EPS, diluted (per share)	2.64	2.89	3.00	3.29	3.24	4.11	4.26	+3.6%
EBITDA	0.7	0.8	0.9	1.0	1.0	1.1	1.1	+1.9%
Depreciation & amortization	0.1	0.2	0.2	0.2	0.2	0.2	0.3	+6.5%
Weighted average shares (shares)	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,010,000	—	—
Weighted average diluted shares (shares)	200,000,000	200,000,000	200,000,000	200,000,000	200,000,000	200,010,000	—	—
Gross margin	47.0%	46.4%	47.1%	47.9%	44.8%	40.6%	40.2%	−0.4 pts
Operating margin	28.3%	29.0%	28.4%	28.0%	25.2%	27.0%	25.7%	−1.2 pts
Net margin	25.8%	27.0%	25.7%	24.3%	22.4%	25.5%	25.2%	−0.3 pts

SAR billionsUpdated Mon 3 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.